<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   &lt;i&gt;Mycoplasma hominis&lt;/i&gt; and &lt;i&gt;Ureaplasma &lt;/i&gt;infections
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       <i>
        Mycoplasma hominis
       </i>
       and
       <i>
        Ureaplasma
       </i>
       infections
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        <i>
         Mycoplasma hominis
        </i>
        and
        <i>
         Ureaplasma
        </i>
        infections
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ken B Waites, MD, F(AAM)
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Namasivayam Ambalavanan, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allyson Bloom, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 23, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H620969258">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Mycoplasma hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         species have been associated with a number of urogenital infections and complications of pregnancy. They also cause various infections at nongenital sites, especially in immunocompromised patients and neonates.
        </p>
        <p>
         The clinical associations, diagnosis, and treatment of infections caused by
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         species will be reviewed here.
        </p>
        <p>
         Infections caused by other pathogenic mycoplasmas, specifically
         <em>
          Mycoplasma pneumoniae
         </em>
         and
         <em>
          Mycoplasma genitalium,
         </em>
         are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6989.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83202.html" rel="external">
          "
          <i>
           Mycoplasma genitalium
          </i>
          infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H35510070">
         <span class="h1">
          MICROBIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H890079416">
         <span class="h2">
          Classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "mycoplasma" is widely used to refer to any organism within the class Mollicutes, which comprises eight genera (including
         <em>
          Mycoplasma
         </em>
         ,
         <em>
          Ureaplasma
         </em>
         ,
         <em>
          Acholeplasma
         </em>
         ,
         <em>
          Anaeroplasma
         </em>
         ,
         <em>
          Entomoplasma, Spiroplasma,
         </em>
         and
         <em>
          Asteroleplasma
         </em>
         ). Over 200 named
         <em>
          Mycoplasma
         </em>
         species exist. Fourteen
         <em>
          Mycoplasma
         </em>
         species, one
         <em>
          Acholeplasma
         </em>
         species, and two
         <em>
          Ureaplasma
         </em>
         species have been isolated from humans on multiple occasions; other species of animal origin have also been rarely detected in humans, usually in immunocompromised patients, and are considered transient colonizers [
         <a href="#rid1">
          1
         </a>
         ]. Only six species, five of which inhabit the genitourinary tract, are established human pathogens:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          M. hominis
         </em>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          M. genitalium
         </em>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Mycoplasma fermentans
         </em>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Ureaplasma
         </em>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Ureaplasma urealyticum
         </em>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Ureaplasma parvum
         </em>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          M. pneumoniae
         </em>
        </p>
        <p>
        </p>
        <p>
         <em>
          Mycoplasma amphoriforme
         </em>
         has been detected in the respiratory tracts of persons with antibody deficiency and chronic bronchitis or bronchiectasis, but its true role as a human pathogen has not been firmly established.
        </p>
        <p class="headingAnchor" id="H2431921932">
         <span class="h2">
          Characteristics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mycoplasmas and ureaplasmas are the smallest free-living organisms. Because they lack a cell wall, neither mycoplasmas nor ureaplasmas can be visualized by Gram stain. In order to culture these organisms, specialized media containing animal serum is required. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p>
         <em>
          Mycoplasma
         </em>
         species typically utilize glucose, arginine, or both as metabolic substrates, but their metabolic properties cannot be used to distinguish them from one another. Ureaplasmas are unique because of their ability to hydrolyze urea [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3908864201">
         <span class="h2">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although
         <em>
          M.
         </em>
         <em>
          hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp normally exist in a state of adherence to mucosal epithelial cells of the urogenital tracts, they can disseminate to other sites and cause infection when there is a disruption of the mucosa (eg, instrumentation, surgery, trauma) and/or an underlying immaturity in host defenses, such as in the developing fetus or premature infant or in persons with immunocompromising conditions, such as antibody deficiencies.
        </p>
        <p>
         <em>
          M. hominis
         </em>
         and ureaplasmas have surface proteins that facilitate cytadherence [
         <a href="#rid2">
          2
         </a>
         ]. Ureaplasmas can attach to erythrocytes, white blood cells, host mucosal cells, and even spermatozoa. Ureaplasmas also produce an IgA protease to degrade immunoglobulins and release ammonia through urealytic activity [
         <a href="#rid1">
          1
         </a>
         ]. The microbiologic burden of genitourinary mycoplasmas may be higher in HIV-infected individuals than in the HIV-uninfected population, and immunosuppression, both cellular and humoral, may contribute to disseminated disease in
         <em>
          M. hominis
         </em>
         - and
         <em>
          Ureaplasma
         </em>
         -infected patients [
         <a href="#rid3">
          3,4
         </a>
         ]. High-rate variation in cell surface protein antigens may facilitate evasion of the host immune system and their persistence in invasive sites [
         <a href="#rid1">
          1
         </a>
         ]
         <strong>
          .
         </strong>
        </p>
        <p class="headingAnchor" id="H3380500245">
         <span class="h1">
          NORMAL GENITAL AND NEONATAL COLONIZATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp
         <em>
         </em>
         are part of the normal genital flora of many sexually experienced males and females [
         <a href="#rid5">
          5
         </a>
         ]. The percentage of females with vaginal colonization with these organisms increases after puberty in proportion to the number of lifetime sexual partners [
         <a href="#rid6">
          6
         </a>
         ]. Transient neonatal colonization also occurs.
        </p>
        <p>
         The rate of colonization wi
         <em>
          th M. hominis
         </em>
         increases more rapidly with increasing sexual experience in females than in males, suggesting that females are more susceptible to colonization [
         <a href="#rid7">
          7
         </a>
         ]. By adulthood, up to 80 percent of healthy females have
         <em>
          Ureaplasma
         </em>
         spp, and 50 percent have
         <em>
          M. hominis
         </em>
         in their cervical or vaginal secretions [
         <a href="#rid2">
          2
         </a>
         ]. Sexually active men are also frequently asymptomatically colonized with
         <em>
          M. hominis
         </em>
         (25 percent in one series of 99 males attending a clinic for sexually transmitted diseases) [
         <a href="#rid8">
          8
         </a>
         ]. Genital colonization may also be associated with lower socioeconomic status.
        </p>
        <p>
         Newborns who are colonized with
         <em>
          Mycoplasma
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp are presumed to have been exposed during passage through the birth canal, since colonization is less common in infants born by caesarean section. Exposure in utero also occurs [
         <a href="#rid1">
          1
         </a>
         ]. Colonization is linked to lower birthweight and gestational age at birth [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Neonatal colonization is transient, and the proportion of infants colonized decreases proportionately with postnatal age [
         <a href="#rid9">
          9
         </a>
         ]. Infants more than three months of age are rarely colonized.
         <em>
          M. hominis
         </em>
         is seldom recovered from prepubertal boys, whereas a small percentage of prepubertal girls have been found to be colonized in some studies, even in the absence of sexual activity or abuse.
        </p>
        <p class="headingAnchor" id="H3875949065">
         <span class="h1">
          GENITOURINARY DISEASE ASSOCIATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2712056765">
         <span class="h2">
          Uncertain role in disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp have been associated with various genitourinary tract infections and complications of pregnancy. However, the precise roles of
         <em>
          Mycoplasma
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp in such diseases have been difficult to define accurately for the following reasons [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Many healthy asymptomatic adults have genitourinary colonization with
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp. (See
         <a class="local">
          'Normal genital and neonatal colonization'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mycoplasmas are rarely the only organisms isolated from a genitourinary specimen, so it is sometimes difficult to distinguish whether they are causative pathogens or simply co-isolates.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Published studies on the pathogenicity of these organisms commonly have important design limitations.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Detection of these organisms has traditionally been difficult and complex. Although newer nucleic acid amplification assays increase detection, they do not necessarily contribute to establishing causality.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2155492950">
         <span class="h2">
          Vaginitis and bacterial vaginosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mollicutes do not cause inflammatory vulvovaginitis; however, the bacterial load of
         <em>
          M. hominis
         </em>
         and, to some extent,
         <em>
          Ureaplasma
         </em>
         spp can be much higher in females with bacterial vaginosis (BV) than in those without this condition. It has therefore been suggested that
         <em>
          M. hominis
         </em>
         acts symbiotically with other BV pathogens (eg,
         <em>
          Gardnerella vaginalis
         </em>
         ) or possibly as a sole pathogen. The strong association of BV with preterm birth also raises the possibility that these organisms might play an etiologic role (see
         <a class="local">
          'Intra-amniotic infection and adverse pregnancy outcomes'
         </a>
         below). Nevertheless, numerous studies performed over several years in various countries have yielded conflicting results on the significance of
         <em>
          M. hominis
         </em>
         in BV, and detailed examination of the vaginal microbiome has not yet provided a definitive answer [
         <a href="#rid1">
          1,10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Pelvic inflammatory disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although
         <em>
          M. hominis
         </em>
         is commonly found in the female genitourinary tract, including among females with pelvic inflammatory disease (PID), the role of
         <em>
          M. hominis
         </em>
         as a cause of PID remains controversial [
         <a href="#rid11">
          11
         </a>
         ]. In one study,
         <em>
          M. hominis
         </em>
         was isolated from 4 of 50 fluid samples taken directly from the fallopian tubes of females with salpingitis versus none of 50 samples from females in the control group [
         <a href="#rid12">
          12
         </a>
         ]. Significant rises or falls in antibody titers to
         <em>
          M. hominis
         </em>
         occurred in 9 of the 16 females with salpingitis who had positive lower genital tract cultures for
         <em>
          M. hominis.
         </em>
         The presence of infection in the absence of changes in antibody titers may reflect the localized nature of salpingitis. However,
         <em>
          M. hominis
         </em>
         is rarely present in patients with salpingitis who do not also have evidence of concurrent chlamydial or gonococcal infections or BV. As a result, its role as a primary pathogen in salpingitis is still uncertain.
         <em>
         </em>
         (See
         <a class="medical medical_review" href="/z/d/html/7580.html" rel="external">
          "Pelvic inflammatory disease: Pathogenesis, microbiology, and risk factors"
         </a>
         .)
        </p>
        <p>
         <em>
          Ureaplasma
         </em>
         spp have been isolated directly from affected fallopian tubes, but not in pure culture. Moreover, negative results of serologic tests, fallopian tube cultures, and non-human primate studies do not support a causal relationship for ureaplasmas as a sole pathogen in PID [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         Neither
         <em>
          M. hominis
         </em>
         nor
         <em>
          Ureaplasma
         </em>
         spp cause cervicitis. We are unaware of a significant association between
         <em>
          Ureaplasma
         </em>
         spp and chronic pelvic pain syndrome.
        </p>
        <p class="headingAnchor" id="H725181">
         <span class="h2">
          Nongonococcal urethritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Ureaplasma
         </em>
         spp have been associated with nongonococcal urethritis (NGU) in some studies [
         <a href="#rid13">
          13
         </a>
         ], but not others [
         <a href="#rid14">
          14,15
         </a>
         ]. In a meta-analysis of studies involving 1507 NGU patients and 1223 controls,
         <em>
          U. urealyticum
         </em>
         was more common in males with NGU [
         <a href="#rid16">
          16
         </a>
         ]. In another study,
         <em>
          U. urealyticum
         </em>
         was significantly associated with NGU only among males with fewer than 10 lifetime heterosexual partners [
         <a href="#rid17">
          17
         </a>
         ]. The authors postulated that adaptive immunity may attenuate the clinical manifestations of
         <em>
          U. urealyticum
         </em>
         infection, so that older males with more exposure to this organism are less likely to have symptoms of NGU from it. However, this hypothesis is not proven, and other explanations are possible. Overall
         <em>
          , U. urealyticum
         </em>
         may be responsible for approximately 3 to 11 percent of NGU cases [
         <a href="#rid18">
          18,19
         </a>
         ]. Other studies have suggested that
         <em>
          U. parvum
         </em>
         can cause NGU, particularly when present in high numbers [
         <a href="#rid18">
          18,20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Nongonococcal urethritis'
         </a>
         .)
        </p>
        <p>
         Ureaplasmas have also been recovered from an epididymal aspirate from a patient suffering from non-chlamydial, nongonococcal, acute epididymo-orchitis accompanied by a specific antibody response [
         <a href="#rid21">
          21
         </a>
         ], and they could be an infrequent cause of the disease.
        </p>
        <p>
         There is no evidence that
         <em>
          M. hominis
         </em>
         causes NGU.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Urinary tract infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp can frequently be recovered from the lower genitourinary tract in males and females, but a causal relationship to cystitis or prostatitis has not been established.
         <em>
          M. hominis
         </em>
         may be responsible for up to 5 percent of cases of acute pyelonephritis, particularly when prior instrumentation has been performed or obstruction is present [
         <a href="#rid11">
          11,22
         </a>
         ].
         <em>
          Ureaplasma
         </em>
         spp have not been shown to cause pyelonephritis. However, they produce urease, induce crystallization of struvite and calcium phosphates in urine in vitro and calculi formation in animal models, and have been found in urinary calculi of patients with infection-associated stones more frequently than in those with metabolic-type stones; these features suggest a possible causal association with urinary tract infection [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         In females, there is no evidence that
         <em>
          M. hominis
         </em>
         is a cause of the urethral syndrome, but ureaplasmas may be involved [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3552554228">
         <span class="h1">
          PREGNANCY-RELATED INFECTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Intra-amniotic infection and adverse pregnancy outcomes
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp are frequently found in the amniotic fluid of females with spontaneous preterm labor, preterm premature rupture of membranes, premature rupture of membranes at term, low birth weight, miscarriage, and stillbirth [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Some of these outcomes are the result of obvious infections, such as chorioamnionitis. Isolation of
         <em>
          Ureaplasma
         </em>
         spp, but not
         <em>
          M. hominis
         </em>
         , from the chorioamnion has been consistently associated with histological chorioamnionitis and is inversely related to birthweight, even when adjusting for duration of labor, rupture of fetal membranes, and presence of other bacteria. These organisms may invade the amniotic cavity when fetal membranes are intact and initiate an inflammatory reaction in the absence of labor [
         <a href="#rid26">
          26
         </a>
         ]. Ureaplasmas are among the most common microorganisms found in inflamed placentas [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6762.html" rel="external">
          "Clinical chorioamnionitis", section on 'Microbiology'
         </a>
         .)
        </p>
        <p>
         Other associations with adverse pregnancy outcomes are more tenuous and may relate to increased colonization rates and titers of the organisms [
         <a href="#rid27">
          27,28
         </a>
         ]. As an example, in a study of asymptomatic pregnant women who underwent amniocentesis during the second trimester, detection of ureaplasmas by polymerase chain reaction (PCR) was associated with a higher rate of subsequent preterm labor and preterm delivery [
         <a href="#rid29">
          29
         </a>
         ]. Maternal ureaplasma colonization has also been linked to low birth weight, neonatal bronchopulmonary dysplasia (BPD), intraventricular hemorrhage, and necrotizing enterocolitis, all of which are associated with prematurity [
         <a href="#rid28">
          28,30
         </a>
         ].
        </p>
        <p>
         Nevertheless, whether these organisms are causal remains controversial, since colonization rates of ureaplasmas (35 to 90 percent) and
         <em>
          M. hominis
         </em>
         (5 to 80 percent) are high in the normal pregnant female population. An additional unclear factor is the role that other organisms, such as those that cause bacterial vaginosis, play in concert with genital mycoplasmas leading to adverse pregnancy outcomes. While PCR-based diagnoses have yielded more information on colonization rates, they have not shed much light on whether these organisms have an etiologic role.
        </p>
        <p>
         The role of these organisms in female infertility is also highly controversial, and no causal relationship has been shown convincingly. In one study, colonization rates were higher in infertile females than in fertile ones, but did not appear to affect pregnancy rates with in vitro fertilization [
         <a href="#rid31">
          31
         </a>
         ].There also appears to be an association between
         <em>
          M. hominis
         </em>
         and ureaplasma colonization rates and male infertility in China [
         <a href="#rid32">
          32
         </a>
         ], but again, no causality has been demonstrated.
        </p>
        <p>
         Some studies have reported that treatment of pregnant women at risk for preterm labor with antimicrobials effective against mycoplasmas and ureaplasmas is associated with prolongation of gestation, and thus suggest that these organisms are responsible for adverse pregnancy outcomes of pregnancy [
         <a href="#rid33">
          33
         </a>
         ]. However, some of the antimicrobials used, such as macrolides, are known to have significant anti-inflammatory effects, and these effects, not the eradication of the organism, may possibly have played a role in the improved outcomes with treatment.
        </p>
        <p class="headingAnchor" id="H3773568409">
         <span class="h2">
          Postpartum and postabortal bacteremia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp can be detected in the bloodstream of females with postpartum or postabortal fever;
         <em>
          M. hominis
         </em>
         is more common at approximately 10 percent of all cases. In one study,
         <em>
          M. hominis
         </em>
         was recovered from blood cultures in 4 of 51 females (8 percent) with fever after abortion; in contrast, blood cultures were negative for
         <em>
          M. hominis
         </em>
         in all control females who had a recent abortion without fever and in all 102 normal pregnant controls [
         <a href="#rid34">
          34
         </a>
         ]. Further evidence in support of
         <em>
          M. hominis
         </em>
         infection was a fourfold rise in antibody titers in approximately one-half of all females who had postabortal fever compared with only 2 of 53 controls who experienced abortion without fever. The higher frequency of antibody production than blood culture recovery suggests that many patients with postabortal fever develop nonbacteremic
         <em>
          M. hominis
         </em>
         infection. However, in another study,
         <em>
          M. hominis
         </em>
         was isolated from the blood in 10 of 327 females (3 percent) who had blood cultures taken a few minutes after delivery; none had fever, and all remained well without treatment [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1021665619">
         <span class="h1">
          NEONATAL DISEASE
         </span>
        </p>
        <p class="headingAnchor" id="H637768513">
         <span class="h2">
          Bacteremia
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp can be isolated from the bloodstream of newborn infants with bacteremia, particularly in preterm infants. One study found that 23 percent of 457 consecutive neonates who were born between 23 and 32 weeks of gestation had positive umbilical blood cultures for
         <em>
          M. hominis
         </em>
         and/or
         <em>
          Ureaplasma
         </em>
         spp [
         <a href="#rid36">
          36
         </a>
         ]. Neonates with positive cultures more often had evidence of inflammatory response syndrome, and their placentas more often had changes compatible with chorioamnionitis than babies with negative blood cultures.
        </p>
        <p>
         Bacteremia in neonates due to
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp can also occur in association with other complications, such as meningitis or pneumonia [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1168059058">
         <span class="h2">
          Lung disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp have been isolated in association with congenital pneumonia in neonates [
         <a href="#rid2">
          2,37
         </a>
         ].
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         pneumonia usually occur early in preterm infants but can also affect term neonates. (See
         <a class="medical medical_review" href="/z/d/html/5004.html" rel="external">
          "Neonatal pneumonia"
         </a>
         .)
        </p>
        <p>
         However, controversy remains about whether colonization with
         <em>
          Ureaplasma
         </em>
         spp contributes to bronchopulmonary dysplasia (BPD), even more than 30 years after the first reports associating ureaplasma colonization of the lower respiratory tracts of preterm neonates with BPD. In a 2005 meta-analysis of 23 studies examining this possible relationship,
         <em>
          Ureaplasma
         </em>
         colonization was associated with chronic lung infection manifesting as long-term oxygen requirements and radiographic changes typical of BPD [
         <a href="#rid38">
          38
         </a>
         ]. A subsequent meta-analysis from 2014 that included 39 studies also found an association between pulmonary colonization with
         <em>
          Ureaplasma
         </em>
         spp and development of BPD in preterm infants at both 36 weeks postmenstrual age and at 28 days of life [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4987.html" rel="external">
          "Bronchopulmonary dysplasia (BPD): Clinical features and diagnosis", section on 'Infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3736791101">
         <span class="h2">
          Meningoencephalitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal meningoencephalitis in association with
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp has been described; acquisition is presumed to have been in utero or via passage through the birth canal [
         <a href="#rid2">
          2,40
         </a>
         ]. The frequency of mycoplasma and ureaplasma isolates from the central nervous system in neonates may be higher than is generally appreciated. In one study,
         <em>
          Mycoplasma
         </em>
         cultures were performed on 100 preterm infants who underwent lumbar puncture for suspected sepsis or meningitis:
         <em>
          M. hominis
         </em>
         was isolated from the cerebrospinal fluid in five, and ureaplasmas were detected in eight [
         <a href="#rid41">
          41
         </a>
         ]. Brain abscess caused by dual infection of
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp has also been reported in a neonate [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2731717657">
         <span class="h2">
          Other complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abscesses, especially at scalp electrode monitoring sites, in neonates due to
         <em>
          M. hominis
         </em>
         have been described in case reports [
         <a href="#rid43">
          43,44
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          OTHER EXTRAGENITAL INFECTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The portal of entry for the mycoplasmas and ureaplasmas that cause nongenitourinary manifestations is almost always the genitourinary tract. Systemic infections caused by
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp are most often noted in immunocompromised persons, particularly those with congenital antibody deficiencies and malignancies, and in organ transplant recipients. Extragenital infections can also occur following instrumentation of the genitourinary tract or postpartum.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Arthritis and osteomyelitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Joint infections have mainly been described in patients with congenital immune defects such as hypogammaglobulinemia, patients with other immunocompromising conditions (eg, solid organ transplant or lymphoma), and following trauma [
         <a href="#rid11">
          11,45-48
         </a>
         ].
         <em>
          M. hominis
         </em>
         arthritis can also occur in females after childbirth [
         <a href="#rid49">
          49
         </a>
         ]. A few patients with prosthetic joint infections due to
         <em>
          M. hominis
         </em>
         have been described [
         <a href="#rid47">
          47,50-53
         </a>
         ].
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp have also been reported occasionally as causes of osteomyelitis in immunosuppressed persons [
         <a href="#rid54">
          54-56
         </a>
         ].
        </p>
        <p>
         <em>
          M. hominis
         </em>
         arthritis is usually characterized by fever, leukocytosis, and a purulent joint effusion with large numbers of polymorphonuclear cells but a negative Gram stain on synovial fluid analysis. In a review of 16 cases of septic arthritis due to
         <em>
          M. hominis
         </em>
         , one-half had undergone manipulation of the urinary tract before the onset of infection [
         <a href="#rid47">
          47
         </a>
         ]. Delays in diagnosis were common, ranging from 5 to 37 days.
         <em>
          Ureaplasma
         </em>
         arthritis may involve one or multiple joints and, in some cases, has been associated with subcutaneous abscesses [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Wound infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         has been associated with infected pelvic hematoma and infected cesarean wounds, as well as other surgical site infections following maxillofacial, abdominal, vascular, cardiothoracic, neurosurgical, and plastic surgical procedures [
         <a href="#rid58">
          58-64
         </a>
         ]. An increasing number of sternal wound infections due to
         <em>
          M. hominis
         </em>
         have been linked to cardiac and lung transplantation [
         <a href="#rid64">
          64
         </a>
         ]. In several cases, transmission of
         <em>
          M. hominis
         </em>
         from donors of transplanted organs or tissue grafts has been supported by genomic sequencing [
         <a href="#rid65">
          65-67
         </a>
         ].
         <em>
          Ureaplasma
         </em>
         spp have also been reported as a cause of postoperative sternal wound infection in a few cases [
         <a href="#rid68">
          68
         </a>
         ]. These are endogenous infections, and there is no evidence for nosocomial transmission. Sterilization of surgical instruments and disinfection of surfaces kill these organisms.
        </p>
        <p>
         In almost all cases, the clinical features of
         <em>
          Mycoplasma
         </em>
         or
         <em>
          Ureaplasma
         </em>
         wound infection are nonspecific. Clues to their presence include the finding of abundant polymorphonuclear leukocytes with a negative Gram stain, negative routine cultures, and a poor response to beta-lactam or aminoglycoside therapy.
        </p>
        <p class="headingAnchor" id="H3702343197">
         <span class="h2">
          Bacteremia and endocarditis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         bacteremia has been demonstrated after renal transplantation, trauma, and genitourinary manipulations.
         <em>
          M. hominis
         </em>
         is a rare cause of prosthetic and native valve endocarditis in adults and children [
         <a href="#rid69">
          69-71
         </a>
         ].
         <em>
          U. parvum
         </em>
         was also reported as a cause endocarditis [
         <a href="#rid56">
          56,72
         </a>
         ]. In one of these case reports,
         <em>
          U. parvum
         </em>
         caused native aortic valve endocarditis more than two years following orchitis and septic arthritis caused by the same organism
         <em>
         </em>
         [
         <a href="#rid72">
          72
         </a>
         ]. Because of difficulties in culturing mycoplasmas and ureaplasmas, such patients present with culture-negative endocarditis. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Culture-negative endocarditis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Respiratory tract infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The significance of
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp in respiratory secretions of adults must be interpreted with caution, but in some instances, they can clearly be of pathogenic significance.
         <em>
          M. hominis
         </em>
         has been isolated from respiratory secretions in 1 to 3 percent of healthy persons, 8 percent of patients with chronic respiratory complaints, and 14 percent of persons engaging in orogenital sex [
         <a href="#rid73">
          73
         </a>
         ].
         <em>
          M. hominis
         </em>
         can cause pharyngitis in volunteers whose nasopharynxes were experimentally inoculated with
         <em>
          M. hominis
         </em>
         . However, attempts to implicate
         <em>
          M. hominis
         </em>
         as a cause of naturally occurring pharyngitis have been unsuccessful [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         One report described seven patients with intensive care unit (ICU)-acquired pneumonia during a four-year period who had cultures from bronchoalveolar lavage or pleural fluid that were positive for
         <em>
          M. hominis
         </em>
         [
         <a href="#rid75">
          75
         </a>
         ]. This report and others describing the recovery of
         <em>
          M. hominis
         </em>
         from lower respiratory tract specimens and/or empyema fluid suggest that
         <em>
          M. hominis
         </em>
         is rarely capable of causing lower respiratory tract infection [
         <a href="#rid75">
          75-77
         </a>
         ]. A case report describes a lung transplant recipient with pneumonia and empyema whose bronchial brush specimen and pleural fluid grew
         <em>
          M. hominis
         </em>
         [
         <a href="#rid76">
          76
         </a>
         ]. Another case report documents
         <em>
          M. hominis
         </em>
         as a cause of necrotizing pleuropneumonia in a previously healthy adolescent [
         <a href="#rid78">
          78
         </a>
         ].
         <em>
          U. parvum
         </em>
         has also been proven as a cause of pneumonia following lung transplantation [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2459361482">
         <span class="h2">
          Central nervous system disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         infection has been associated with nonfunctioning central nervous system (CNS) shunts [
         <a href="#rid60">
          60
         </a>
         ], brain abscess [
         <a href="#rid80">
          80,81
         </a>
         ], subdural empyema [
         <a href="#rid82">
          82
         </a>
         ], and meningitis [
         <a href="#rid83">
          83
         </a>
         ].
         <em>
          U. urealyticum
         </em>
         has been detected in the cerebrospinal fluid (CSF) of an adult with meningitis, which developed 10 weeks after a complicated kidney transplantation with organ rejection [
         <a href="#rid84">
          84
         </a>
         ],
         <strong>
         </strong>
         and in a brain abscess of an adult with congenital hypogammaglobulinemia
         <strong>
         </strong>
         [
         <a href="#rid85">
          85
         </a>
         ].
         <strong>
         </strong>
         Disseminated ureaplasma infection involving CSF, kidney, pelvic abscess, skin, and subcutaneous tissue has also been reported in association with hypogammaglobulinemia, underscoring the importance of an intact immune system to prevent and control systemic infections caused by these organisms
         <strong>
         </strong>
         [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2804870890">
         <span class="h2">
          Post-transplant hyperammonemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperammonemia syndrome is a rare but potentially fatal post-transplant complication primarily in lung transplant recipients. This complication has also been demonstrated following hematopoietic cell transplantation. The cause is not definitively known, but evidence suggests it is associated with
         <em>
          Ureaplasma
         </em>
         spp and
         <em>
          M. hominis
         </em>
         infection. In some instances, infection is donor-derived. Any lung transplant recipient with elevated ammonia levels should be evaluated for the presence of these organisms using culture or nucleic acid amplification testing [
         <a href="#rid79">
          79,87-90
         </a>
         ]. This is discussed in further detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4656.html" rel="external">
          "Noninfectious complications following lung transplantation", section on 'Hyperammonemia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H725159">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H3287450351">
         <span class="h2">
          Clinical suspicion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although infections with
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp are relatively uncommon, their possibility should be considered in preterm neonates and immunocompromised patients who present with evidence of the associated conditions detailed above, particularly systemic infection (eg, sepsis), pneumonia, central nervous system infection, or new-onset arthritis (see
         <a class="local">
          'Neonatal disease'
         </a>
         above and
         <a class="local">
          'Other extragenital infections'
         </a>
         above). The suspicion for these organisms should be heightened when initial microbiologic testing (eg, Gram stain and early routine culture) is negative or uninformative or if the patient does not improve on antimicrobial therapy for more common pathogens (eg, with beta-lactams). Similarly, they should be suspected in immunocompromised patients with wound or surgical site infections (including sternal wound infections) when routine cultures are negative.
        </p>
        <p>
         In such cases, microbiologic testing for
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp should be performed (see
         <a class="local">
          'Microbiologic confirmation'
         </a>
         below). Nevertheless, given the difficulty in obtaining a microbiological diagnosis, empiric antimicrobial therapy is often warranted based on this clinical suspicion alone in vulnerable patients. (See
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p>
         Unfortunately, many infections eventually proven to be caused by these organisms remain undiagnosed for long periods of time, because specific microbiologic testing is either unavailable in clinical laboratories or simply has not been requested. Despite the relative infrequency of these organisms, it is important to maintain a high index of suspicion, since the patients in whom these infections occur are at high risk for adverse outcomes.
        </p>
        <p>
         Routine testing for
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp in patients with uncomplicated genital tract disease is not warranted; it is uncertain whether detection of such organisms in the genital tract reflects normal colonization or infection [
         <a href="#rid91">
          91
         </a>
         ]. (See
         <a class="local">
          'Uncertain role in disease'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3437152971">
         <span class="h2">
          Microbiologic confirmation
         </span>
         <span class="headingEndMark">
          —
         </span>
         With the exception of
         <em>
          M. hominis,
         </em>
         which will sometimes grow in routine bacteriologic media, special procedures and media are required for detection of these organisms in clinical specimens. Both culture and nucleic acid amplification tests can be used for their detection; the choice between them generally depends on availability and turnaround time. Serology is not useful, since many healthy people have underlying antibodies, and in the United States, there are no standardized commercial serologic assays available.
        </p>
        <p class="headingAnchor" id="H105010013">
         <span class="h3">
          Culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         and ureaplasmas often grow in broth cultures within 24 to 48 hours. Most hospital microbiology laboratories do not perform cultures for these organisms, but they are readily available through reference laboratories. The isolation of
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp in any quantity from normally sterile body fluids or tissues is diagnostic of infection, particularly in neonates or other immunosuppressed persons. Susceptibility testing should be performed if these organisms are isolated on culture of extragenital sites, but it is mainly limited to reference laboratories.
        </p>
        <p>
         Appropriate clinical specimens (eg, blood, cerebrospinal fluid [CSF], synovial fluid, sputum) depend on the clinical syndrome suspected. Ideally, they should be inoculated immediately into broth culture media containing animal serum before they are allowed to dry. If this is not available or if a delay in laboratory receipt or processing is anticipated, the specimen can be collected in some type of universal transport medium or mycoplasma broth culture media that does not contain antibiotics that would be inhibitory [
         <a href="#rid92">
          92
         </a>
         ]. Specimens in transport media must be refrigerated or frozen prior to shipment, depending on the time until they are expected to be received in a reference laboratory for processing.
        </p>
        <p>
         Liquid and solid media used for culturing these organisms, such as 10B broth for
         <em>
          Ureaplasma
         </em>
         spp and SP4 broth for
         <em>
          Mycoplasma
         </em>
         spp, have pH-sensitive dye indicators that help distinguish the urea splitters (ureaplasmas) and ammonia metabolizers (
         <em>
          M. hominis
         </em>
         ), which turn media alkaline, from glucose metabolizers (
         <em>
          M. pneumoniae
         </em>
         ), which turn media acidic. Specimens should be subcultured onto SP4 agar plates for definitive identification of
         <em>
          M. hominis
         </em>
         and onto A8 agar plates for
         <em>
          Ureaplasma
         </em>
         spp. Genital mycoplasma colonies develop best when incubated in air plus 5% CO
         <sub>
          2
         </sub>
         or under anaerobic conditions.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          M. hominis
         </em>
         may take a week to develop discernible colonies. It can escape detection using automated blood culture detection systems, such as BacT/ALERT [
         <a href="#rid93">
          93
         </a>
         ], unless cultures are routinely incubated for three to five days using special media and/or blind subcultures are made from blood cultures [
         <a href="#rid7">
          7
         </a>
         ].
         <em>
          M. hominis
         </em>
         colonies look like a "fried egg," having a denser center and paler outer zone.
         <em>
          M. hominis
         </em>
         can also show up on routine bacterial media as pinpoint colonies that cannot be visualized on Gram stain. An arginine-utilizing mycoplasma that produces fried-egg colonies on SP4 agar within three to four days is most likely
         <em>
          M. hominis
         </em>
         , but a polymerase chain reaction (PCR) assay is necessary for species confirmation, since commensal mycoplasmas may behave in a similar manner.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ureaplasmas may grow in one to two days. They form tiny pinpoint colonies with a brown granular appearance on A8 agar when viewed under a stereomicroscope. Their appearance is sufficient for identification to genus level. Differentiation of
         <em>
          Ureaplasma
         </em>
         spp requires testing by the PCR assay [
         <a href="#rid94">
          94
         </a>
         ], but this is not necessary for routine diagnostic purposes.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H105010020">
         <span class="h3">
          Nucleic acid-based tests (including PCR)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nucleic acid-based tests, such as the PCR assay, are more easily performed and generally more sensitive than culture methods and can theoretically be completed in a single day [
         <a href="#rid95">
          95
         </a>
         ]. However, they are not available in most hospital diagnostic laboratories. In the United States, there are no Food and Drug Administration-cleared nucleic acid-based assays for these organisms, although several reference labs have developed and validated their own assays using a variety of gene targets and techniques. Any specimen suitable for culture can also be tested with nucleic acid-based tests (eg, throat swabs, tracheal aspirates or sputum, pleural or synovial fluid, tissue or bone, CSF).
        </p>
        <p>
         Nucleic acid-based assays can help in assigning causality when material from sites not ordinarily colonized (eg, joint fluid or tissue, heart valve tissue, CSF) are tested. However, positive nucleic acid tests on specimens from sites that are frequently colonized with multiple organisms (eg, genital tract) are less helpful and should not be considered diagnostic unless other causes of infection have been ruled out.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H4264849386">
         <span class="h2">
          Indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients should be treated for a
         <em>
          Mycoplasma
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp infection if they have a compatible clinical syndrome with detection of
         <em>
          Mycoplasma
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp from a normally sterile extragenital site, from lower respiratory tract specimens, or from infected wound specimens. Immunocompromised patients who present with a compatible clinical syndrome also warrant empiric treatment given the difficulty in obtaining a timely microbiologic diagnosis. The clinical diagnosis is discussed elsewhere. (See
         <a class="local">
          'Clinical suspicion'
         </a>
         above.)
        </p>
        <p>
         Treatment is not warranted for patients who are found to be colonized with these organisms but do not have clinical disease. For infections that are commonly polymicrobial, such as pelvic inflammatory disease (PID), if
         <em>
          M. hominis
         </em>
         is one of several organisms detected, it is reasonable to include coverage for the mycoplasmas as part of the broader spectrum regimen. However, there is no definitive evidence that this affects patient outcomes.
        </p>
        <p class="headingAnchor" id="H3508992565">
         <span class="h2">
          In vitro susceptibility
         </span>
         <span class="headingEndMark">
          —
         </span>
         In vitro antimicrobial susceptibility testing has been standardized for human mycoplasmas and ureaplasmas, and there are interpretive criteria for minimum inhibitory concentrations (MICs) for several antimicrobial agents used for treatment of infections caused by these organisms [
         <a href="#rid96">
          96
         </a>
         ].
         <strong>
         </strong>
        </p>
        <p>
         Acquired resistance to one or more classes of antimicrobial agents has been well documented in
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp. The extent and frequency of resistance varies according to geographic area, type of patient population, and previous exposure to antimicrobial agents.
        </p>
        <p>
         Susceptibility testing results are usually not available when selecting an antibiotic regimen, since treatment is often empiric or infections are detected by molecular tests. In vitro susceptibility testing is available through reference laboratories and should be pursued whenever there is treatment failure, in infections in immunocompromised patients, and for extragenital infections in normally sterile sites.
        </p>
        <p class="headingAnchor" id="H2771255089">
         <span class="h3">
          Mycoplasma hominis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. hominis
         </em>
         is generally susceptible in vitro to the following agents:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tetracyclines (eg,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         ) [
         <a href="#rid97">
          97-99
         </a>
         ]. However, in some patient populations, resistance has been reported in up to 15 to 40 percent [
         <a href="#rid1">
          1,97,100
         </a>
         ]. Resistance results from ribosomal protection due to the
         <em>
          tetM
         </em>
         transposon.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         [
         <a href="#rid97">
          97-99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fluoroquinolones (eg,
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         and
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         ) [
         <a href="#rid101">
          101,102
         </a>
         ]. Naturally occurring resistance caused by mutations in
         <em>
          parC
         </em>
         and
         <em>
          parE
         </em>
         in the chromosomal quinolone resistance determining regions can occur in a small percentage of clinical isolates [
         <a href="#rid103">
          103
         </a>
         ]. In one French study, quinolone resistance was less than 3 percent between 2010 and 2015 [
         <a href="#rid100">
          100
         </a>
         ]. Resistance can also be induced in vitro by increasing concentrations of fluoroquinolones.
        </p>
        <p>
        </p>
        <p>
         <em>
          M. hominis
         </em>
         is generally resistant in vitro to macrolides (14- and 15-membered agents such as
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         , and
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         ), aminoglycosides, sulfonamide,
         <a class="drug drug_general" data-topicid="10024" href="/z/d/drug information/10024.html" rel="external">
          trimethoprim
         </a>
         , and all beta-lactams [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H418991379">
         <span class="h3">
          Ureaplasma spp
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Ureaplasma
         </em>
         spp are generally susceptible to the following agents:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tetracyclines (eg,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         ) [
         <a href="#rid97">
          97-99
         </a>
         ]. Resistance is fairly uncommon, occurring in approximately 8 percent of clinical isolates from 2010 to 2015 in a French study [
         <a href="#rid100">
          100
         </a>
         ]. In the United States, 33 to 45 percent of clinical isolates were reported to contain the
         <em>
          tetM
         </em>
         transposon that confers resistance by ribosomal protection [
         <a href="#rid1">
          1,104
         </a>
         ]. However, a more recent study from the United States reported doxycycline resistance in only 1 of 202
         <em>
          U. parvum
         </em>
         isolates [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macrolides (
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         ). Resistance due to mutations in 23S ribosomal RNA or ribosomal proteins has been described and is associated with treatment failures [
         <a href="#rid87">
          87
         </a>
         ]. In the United States, such resistance remains uncommon [
         <a href="#rid104">
          104,105
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fluoroquinolones (eg,
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         and
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         ) [
         <a href="#rid102">
          102
         </a>
         ]. Naturally occurring resistance caused by mutations in
         <em>
          parC
         </em>
         and
         <em>
          parE
         </em>
         in the chromosomal quinolone resistance-determining regions is known to occur in a small percentage of clinical isolates [
         <a href="#rid103">
          103
         </a>
         ]. In a study from the United States, levofloxacin resistance rate was 6 percent for
         <em>
          U. parvum
         </em>
         and 5 percent for
         <em>
          U. urealyticum
         </em>
         [
         <a href="#rid105">
          105
         </a>
         ].
         <em>
         </em>
         Resistance can also be induced in vitro by increasing concentrations of fluoroquinolones.
        </p>
        <p>
        </p>
        <p>
         <em>
          Ureaplasma
         </em>
         spp are generally resistant in vitro to
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         , aminoglycosides, sulfonamides,
         <a class="drug drug_general" data-topicid="10024" href="/z/d/drug information/10024.html" rel="external">
          trimethoprim
         </a>
         , and all beta-lactams.
        </p>
        <p class="headingAnchor" id="H2165665580">
         <span class="h2">
          Regimen selection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The choice of drug, route of administration, dosage, and duration of therapy depend on the type of patient (ie, neonate, child, or adult), clinical condition (whether a urogenital infection or infection in a sterile site such as bloodstream or cerebrospinal fluid [CSF]), type of host (normal or immunosuppressed), and severity of infection.
        </p>
        <p>
         Regimen selection is based primarily on an understanding of the in vitro susceptibility patterns of these organisms, although susceptibility testing results have not been extensively correlated with treatment outcomes beyond individual case reports. There are no specific treatment guidelines issued by any professional or regulatory organization. (See
         <a class="local">
          'In vitro susceptibility'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1262959929">
         <span class="h3">
          Neonatal infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical evidence informing the treatment of neonatal
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         infections is limited to case reports or small case series.
        </p>
        <p>
         Systemic neonatal infections caused by
         <em>
          M. hominis
         </em>
         are uncommon. The organism is variably susceptible to
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         , and fluoroquinolones. Dosing of clindamycin in newborn infants should be based on postmenstrual age. Experience with doxycycline and fluoroquinolone use in premature infants is limited.
        </p>
        <p>
         A positive
         <em>
          Ureaplasma
         </em>
         spp culture does not indicate need for therapy if the infant is asymptomatic. Although in vitro efficacy against
         <em>
          Ureaplasma
         </em>
         spp is observed with
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         , and fluoroquinolones, a lack of benefit precludes recommendations on treatment for preterm infants. Definitive evidence on efficacy of antimicrobial agents in the treatment of central nervous system (CNS)
         <em>
          Ureaplasma
         </em>
         spp infections in infants is also lacking. Sterility of CSF can occur without antimicrobial therapy [
         <a href="#rid106">
          106
         </a>
         ].
        </p>
        <p>
         If treatment is provided for
         <em>
          Ureaplasma
         </em>
         spp,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         (10 mg/kg intravenously [IV] daily) is an option. An association exists between orally administered azithromycin and pyloric stenosis in infants younger than six weeks of age. Infants treated with azithromycin should be followed for signs and symptoms of pyloric stenosis.
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          Erythromycin
         </a>
         should be avoided given its association with pyloric stenosis. Experience with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         in premature infants is limited. In one study of preterm infants, azithromycin was apparently effective in eradication of ureaplasmas from the respiratory tract [
         <a href="#rid2">
          2,107
         </a>
         ].
        </p>
        <p>
         There are no specific guidelines, but the duration of antibiotic therapy depends on the type of infection being treated and is generally 10 to 14 days.
        </p>
        <p class="headingAnchor" id="H2556344617">
         <span class="h3">
          Extragenital infections in other populations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most extragenital infections occur in adults with underlying immunocompromising conditions. We suggest a fluoroquinolone as first-line therapy for extragenital
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp infections, based on typical in vitro susceptibility and because the fluoroquinolones have the advantage of being bactericidal. The preferred fluoroquinolones are
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         (400 mg orally or IV once daily) and
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         (500 mg orally or IV once daily).
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         (200 mg loading dose then 100 mg orally or IV twice daily) is an appropriate alternative agent. If possible, directed regimen selection should be guided by in vitro susceptibility testing. (See
         <a class="local">
          'Culture'
         </a>
         above.)
        </p>
        <p>
         Although there is no clear evidence that combination therapy (eg, a fluoroquinolone plus
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         ) results in better outcomes than monotherapy, it has been described [
         <a href="#rid53">
          53,108,109
         </a>
         ] and is a reasonable approach in immunocompromised patients. In such patients, particularly in those with hypogammaglobulinemia,
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp have the capacity to produce destructive and progressive disease. Furthermore, infections may be caused by resistant organisms, and combination therapy potentially increases the likelihood of using an active agent pending susceptibility results.
        </p>
        <p>
         In severe infections, immunosuppression should be reduced, if possible; patients with hypogammaglobulinemia should receive replacement
         <a class="drug drug_general" data-topicid="16471" href="/z/d/drug information/16471.html" rel="external">
          immune globulin
         </a>
         . Some infections (eg, bone and joint infections, deep wound infections) also warrant aggressive debridement and drainage of infected or necrotic tissue.
        </p>
        <p>
         The duration of therapy varies with the severity of disease, the site of infection, the immune status of the patient, and response to therapy. In some cases, such as with bone infections, several weeks of therapy are warranted [
         <a href="#rid47">
          47,50
         </a>
         ]. Some reports describe administering antibiotics for up to a year [
         <a href="#rid110">
          110
         </a>
         ].
        </p>
        <p>
         Even with aggressive therapy, relapses are likely to occur. Repeat cultures of affected sites, such as synovial fluid, may be necessary to monitor in vivo response to treatment.
        </p>
        <p>
         Clinical data to support the use of fluoroquinolones are mainly from case reports and series [
         <a href="#rid111">
          111
         </a>
         ].
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          Moxifloxacin
         </a>
         is more potent than
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         in vitro, but there are no data to demonstrate that it provides a more efficacious clinical or microbiologic outcome in vivo.
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         has also been used successfully, including in CNS and bone infections [
         <a href="#rid42">
          42,84,112
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2363539903">
         <span class="h3">
          Uncomplicated urogenital infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         If treatment is warranted for an uncomplicated urogenital infection caused by
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg orally twice daily) is the drug of choice for nonpregnant adults and adolescents. Duration of therapy is generally seven days for lower urogenital tract infection, whereas for more extensive infections, such as PID, antibiotics are given for 14 days. We also offer treatment to sexual partners regardless of symptoms because of the potential of sexual transmission.
        </p>
        <p>
         Despite in vitro susceptibility,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         or macrolide treatment of vaginal mycoplasmas and ureaplasmas is not always successful. Furthermore, some populations have a risk of acquired
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         resistance. In cases of treatment failure or resistance, fluoroquinolones are another option.
        </p>
        <p>
         For pregnant women and young children,
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         is appropriate for
         <em>
          M. hominis
         </em>
         infections and a macrolide (such as
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         ) is appropriate for
         <em>
          Ureaplasma
         </em>
         infections. These are also appropriate alternative agents in nonpregnant adults or adolescents who cannot take
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         .
        </p>
        <p>
         Regimen selection for urogenital infection is based primarily on in vitro susceptibility patterns (see
         <a class="local">
          'In vitro susceptibility'
         </a>
         above) and outcomes of clinical trials of nongonococcal urethritis and other genital infections that have used
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         successfully. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Nongonococcal urethritis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H296317">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         –
         <em>
          Mycoplasma hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp are small bacteria that lack a cell wall and cannot be visualized by Gram stain. They are part of the normal genital flora of sexually experienced individuals; transient neonatal colonization also occurs. (See
         <a class="local">
          'Microbiology'
         </a>
         above and
         <a class="local">
          'Normal genital and neonatal colonization'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated genitourinary syndromes
         </strong>
         – These organisms have been associated with various genitourinary tract infections (eg, pelvic inflammatory disease for
         <em>
          M. hominis
         </em>
         and nongonococcal urethritis for
         <em>
          Ureaplasma
         </em>
         spp), as well as complications of pregnancy, but their precise roles in some of these conditions have been difficult to define. (See
         <a class="local">
          'Genitourinary disease associations'
         </a>
         above and
         <a class="local">
          'Pregnancy-related infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Populations at risk for extragenital infection
         </strong>
         –
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         can cause severe infection in specific populations. Neonatal infections include meningoencephalitis, bacteremia, and pneumonia, mainly in preterm infants. In immunocompromised patients, severe systemic infections (eg, bacteremia and bone, joint, pulmonary, and central nervous system infections) have also been described; extragenital infections can also occur following trauma or instrumentation of the genitourinary tract. (See
         <a class="local">
          'Neonatal disease'
         </a>
         above and
         <a class="local">
          'Other extragenital infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical suspicion and diagnosis
         </strong>
         – Although relatively uncommon,
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp infection should be suspected in preterm neonates and immunocompromised patients with extragenital infections when initial microbiologic testing is negative or if the patient does not improve on therapy for more common pathogens. Both culture and nucleic acid amplification tests can be used for their detection; if these organisms are isolated, susceptibility testing should be performed, if available. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neonatal infection
         </strong>
         – For neonates, data on the treatment of
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp infections are extremely limited.
         <em>
          M. hominis
         </em>
         is variably susceptible to
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         , tetracyclines, and fluoroquinolones. Clindamycin should be dosed according to postmenstrual age; experience with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         and fluoroquinolones in premature infants is limited. If treatment is warranted for
         <em>
          Ureaplasma
         </em>
         spp,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         is an option. (See
         <a class="local">
          'Neonatal infections'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Extragenital infection in other populations
         </strong>
         – For extragenital
         <em>
          M. hominis
         </em>
         and
         <em>
          Ureaplasma
         </em>
         spp infections in nonpregnant individuals, we suggest
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         or
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          Doxycycline
         </a>
         is an appropriate alternative, although resistance may be increasing; it is also reasonable to use combination therapy (eg, moxifloxacin or levofloxacin plus doxycycline). Clinical data on the optimal treatment of these organisms are limited; our preference for certain regimens are based mainly on in vitro susceptibility data and safety in different populations. (See
         <a class="local">
          'Extragenital infections in other populations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Genital infection
         </strong>
         – Routine testing for
         <em>
          M. hominis
         </em>
         or
         <em>
          Ureaplasma
         </em>
         spp in patients with uncomplicated genital tract disease is not warranted. If these organisms are detected in patients with a genitourinary syndrome (eg, nongonococcal urethritis or pelvic inflammatory disease) and are thought to be the cause of the symptoms, we suggest
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Uncertain role in disease'
         </a>
         above and
         <a class="local">
          'Uncomplicated urogenital infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3756690833">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Stephen G Baum, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Schelonka RL, Xiao L, et al. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonatal Med 2009; 14:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redelinghuys MJ, Ehlers MM, Dreyer AW, et al. A cross-sectional study on the relationship of age, gestational age and HIV infection to bacterial vaginosis and genital mycoplasma infection. BMJ Open 2015; 5:e008530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis 1993; 17 Suppl 1:S243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormack WM, Rosner B, Lee YH. Colonization with genital mycoplasmas in women. Am J Epidemiol 1973; 97:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormack WM, Almeida PC, Bailey PE, et al. Sexual activity and vaginal colonization with genital mycoplasmas. JAMA 1972; 221:1375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D, McCormack WM. The genital mycoplasmas (first of two parts). N Engl J Med 1980; 302:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee YH, Rosner B, Alpert S, et al. Clinical and microbiological investigation of men with urethritis. J Infect Dis 1978; 138:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foy HM, Kenny GE, Levinsohn EM, Grayston JT. Acquisition of mycoplasmata and T-strains during infancy. J Infect Dis 1970; 121:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res Microbiol 2017; 168:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 1996; 23:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mårdh PA, Weström L. Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasmas. Br J Vener Dis 1970; 46:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Povlsen K, Bjørnelius E, Lidbrink P, Lind I. Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Infect Dis 2002; 21:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Totten PA, Schwartz MA, Sjöström KE, et al. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001; 183:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193:336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang N, Wang R, Li X, et al. Are Ureaplasma spp. a cause of nongonococcal urethritis? A systematic review and meta-analysis. PLoS One 2014; 9:e113771.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wetmore CM, Manhart LE, Lowens MS, et al. Ureaplasma urealyticum is associated with nongonococcal urethritis among men with fewer lifetime sexual partners: a case-control study. J Infect Dis 2011; 204:1274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox C, McKenna JP, Watt AP, Coyle PV. Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting. Int J STD AIDS 2016; 27:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couldwell DL, Gidding HF, Freedman EV, et al. Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD AIDS 2010; 21:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deguchi T, Shimada Y, Horie K, et al. Bacterial loads of Ureaplasma parvum contribute to the development of inflammatory responses in the male urethra. Int J STD AIDS 2015; 26:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jalil N, Doble A, Gilchrist C, Taylor-Robinson D. Infection of the epididymis by Ureaplasma urealyticum. Genitourin Med 1988; 64:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomsen AC, Lindskov HO. Diagnosis of Mycoplasma hominis pyelonephritis by demonstration of antibodies in urine. J Clin Microbiol 1979; 9:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grenabo L, Hedelin H, Pettersson S. Urinary infection stones caused by Ureaplasma urealyticum: a review. Scand J Infect Dis Suppl 1988; 53:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stamm WE, Running K, Hale J, Holmes KK. Etiologic role of Mycoplasma hominis and Ureaplasma urealyticum in women with the acute urethral syndrome. Sex Transm Dis 1983; 10:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romero R, Garite TJ. Twenty percent of very preterm neonates (23-32 weeks of gestation) are born with bacteremia caused by genital Mycoplasmas. Am J Obstet Gynecol 2008; 198:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis 2013; 26:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viscardi RM. Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed 2014; 99:F87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gerber S, Vial Y, Hohlfeld P, Witkin SS. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003; 187:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murtha AP, Edwards JM. The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin North Am 2014; 41:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sleha R, Boštíková V, Hampl R, et al. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum in women undergoing an initial infertility evaluation. Epidemiol Mikrobiol Imunol Fall; 65:232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang C, Zhu HL, Xu KR, et al. Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta-analysis. Andrology 2015; 3:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vouga M, Greub G, Prod'hom G, et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect 2014; 20:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harwick HJ, Purcell RH, Iuppa JB, Fekety FR Jr. Mycoplasma hominis and abortion. J Infect Dis 1970; 121:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormack WM, Rosner B, Lee YH, et al. Isolation of genital mycoplasmas from blood obtained shortly after vaginal delivery. Lancet 1975; 1:596.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008; 198:43.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Resch B, Gutmann C, Reiterer F, et al. Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics. Infection 2016; 44:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schelonka RL, Katz B, Waites KB, Benjamin DK Jr. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 2005; 24:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lowe J, Watkins WJ, Edwards MO, et al. Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis. Pediatr Infect Dis J 2014; 33:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alonso-Vega C, Wauters N, Vermeylen D, et al. A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn. J Clin Microbiol 1997; 35:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Rudd PT, Crouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1988; 1:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao RP, Ghanayem NS, Kaufman BA, et al. Mycoplasma hominis and Ureaplasma species brain abscess in a neonate. Pediatr Infect Dis J 2002; 21:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdel-Haq N, Asmar B, Brown W. Mycoplasma hominis scalp abscess in the newborn. Pediatr Infect Dis J 2002; 21:1171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sacker I, Walker M, Brunell PA. Abscess in newborn infants caused by Mycoplasma. Pediatrics 1970; 46:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steuer A, Franz A, Furr PM, et al. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis. J Infect 1996; 33:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonald MI, Moore JO, Harrelson JM, et al. Septic arthritis due to Mycoplasma hominis. Arthritis Rheum 1983; 26:1044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luttrell LM, Kanj SS, Corey GR, et al. Mycoplasma hominis septic arthritis: two case reports and review. Clin Infect Dis 1994; 19:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           George MD, Cardenas AM, Birnbaum BK, Gluckman SJ. Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis. J Clin Rheumatol 2015; 21:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D, Thomas BJ, Furr PM, Keat AC. The association of Mycoplasma hominis with arthritis. Sex Transm Dis 1983; 10:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Méchaï F, Le Moal G, Duchêne S, et al. Mycoplasma hominis osteitis in an immunocompetent man. Eur J Clin Microbiol Infect Dis 2006; 25:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roerdink RL, Douw CM, Leenders AC, et al. Bilateral periprosthetic joint infection with Ureaplasma urealyticum in an immunocompromised patient. Infection 2016; 44:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qiu HJ, Lu WP, Li M, et al. The infection of Mycoplasma hominis after total knee replacement: Case report and literature review. Chin J Traumatol 2017; 20:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiang L, Lu B. Infection due to Mycoplasma hominis after left hip replacement: case report and literature review. BMC Infect Dis 2019; 19:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noska A, Nasr R, Williams DN. Closed trauma, Mycoplasma hominis osteomyelitis, and the elusive diagnosis of Good's syndrome. BMJ Case Rep 2012; 2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohiuddin AA, Corren J, Harbeck RJ, et al. Ureaplasma urealyticum chronic osteomyelitis in a patient with hypogammaglobulinemia. J Allergy Clin Immunol 1991; 87:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frangogiannis NG, Cate TR. Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature. J Infect 1998; 37:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gassiep I, Gore L, Dale JL, Playford EG. Ureaplasma urealyticum necrotizing soft tissue infection. J Infect Chemother 2017; 23:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ti TY, Dan M, Stemke GW, et al. Isolation of Mycoplasma hominis from the blood of men with multiple trauma and fever. JAMA 1982; 247:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuchí E, Cherta I, Garau J. Mycoplasma hominis catheter-related infection in a patient with multiple trauma. Clin Microbiol Infect 2000; 6:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis 1988; 10:602.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee YH, Nersasian RR, Nguyen-Kim-Lan, et al. Wound infection with Mycoplasma hominis. JAMA 1971; 218:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mossad SB, Rehm SJ, Tomford JW, et al. Sternotomy infection with Mycoplasma hominis: a cause of "culture negative" wound infection. J Cardiovasc Surg (Torino) 1996; 37:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mori N, Takigawa A, Kagawa N, et al. Pelvic abscess due to Mycoplasma hominis following caesarean section. JMM Case Rep 2016; 3:e005059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins PM, Winlaw DS, Chhajed PN, et al. Mycoplasma hominis infection in heart and lung transplantation. J Heart Lung Transplant 2002; 21:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampath R, Patel R, Cunningham SA, et al. Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission. EBioMedicine 2017; 19:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smibert OC, Wilson HL, Sohail A, et al. Donor-Derived Mycoplasma hominis and an Apparent Cluster of M. hominis Cases in Solid Organ Transplant Recipients. Clin Infect Dis 2017; 65:1504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Novosad SA, Basavaraju SV, Annambhotla P, et al. Mycoplasma hominis Infections Transmitted Through Amniotic Tissue Product. Clin Infect Dis 2017; 65:1152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walkty A, Lo E, Manickam K, et al. Ureaplasma parvum as a cause of sternal wound infection. J Clin Microbiol 2009; 47:1976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blasco M, Torres L, Marco ML, et al. Prosthetic valve endocarditis caused by Mycoplasma hominis. Eur J Clin Microbiol Infect Dis 2000; 19:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fenollar F, Gauduchon V, Casalta JP, et al. Mycoplasma endocarditis: two case reports and a review. Clin Infect Dis 2004; 38:e21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dominguez SR, Littlehorn C, Nyquist AC. Mycoplasma hominis endocarditis in a child with a complex congenital heart defect. Pediatr Infect Dis J 2006; 25:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korytny A, Nasser R, Geffen Y, et al. Ureaplasma parvum causing life-threatening disease in a susceptible patient. BMJ Case Rep 2017; 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MUFSON MA, LUDWIG WM, PURCELL RH, et al. EXUDATIVE PHARYNGITIS FOLLOWING EXPERIMENTAL MYCOPLASMA HOMINIS: TYPE 1 INFECTION. JAMA 1965; 192:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mufson MA. Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Dis 1983; 10:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García C, Ugalde E, Monteagudo I, et al. Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit. Intensive Care Med 2007; 33:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyon GM, Alspaugh JA, Meredith FT, et al. Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature. Chest 1997; 112:1428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vogel U, Lüneberg E, Kuse ER, et al. Extragenital Mycoplasma hominis infection in two liver transplant recipients. Clin Infect Dis 1997; 24:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pascual A, Perez MH, Jaton K, et al. Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent. BMC Infect Dis 2010; 10:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez R, Ratliff A, Crabb D, et al. Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung Transplantation. Ann Thorac Surg 2017; 103:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergin SM, Mendis SM, Young B, Binti Izharuddin E. Postoperative Mycoplasma hominis brain abscess: keep it in mind! BMJ Case Rep 2017; 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kupila L, Rantakokko-Jalava K, Jalava J, et al. Brain abscess caused by Mycoplasma hominis: a clinically recognizable entity? Eur J Neurol 2006; 13:550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong JS, Tseung SY, Lam HS, et al. Successful treatment of multiple subdural empyemata caused by Mycoplasma hominis in a newborn. Neonatology 2009; 95:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hata A, Honda Y, Asada K, et al. Mycoplasma hominis meningitis in a neonate: case report and review. J Infect 2008; 57:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geissdörfer W, Sandner G, John S, et al. Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol 2008; 46:1141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deetjen P, Maurer C, Rank A, et al. Brain abscess caused by Ureaplasma urealyticum in an adult patient. J Clin Microbiol 2014; 52:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordtz J, Jensen JS. Disseminated Ureaplasma urealyticum infection in a hypo-gammaglobulinaemic renal transplant patient. Scand J Infect Dis 2006; 38:1114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bharat A, Cunningham SA, Scott Budinger GR, et al. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med 2015; 7:284re3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wylam ME, Kennedy CC, Hernandez NM, et al. Fatal hyperammonaemia caused by Mycoplasma hominis. Lancet 2013; 382:1956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graetz R, Meyer R, Shehab K, Katsanis E. Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection. Transpl Infect Dis 2018; 20:e12839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nowbakht C, Edwards AR, Rodriguez-Buritica DF, et al. Two Cases of Fatal Hyperammonemia Syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients Outside Lung Transplant Recipients. Open Forum Infect Dis 2019; 6:ofz033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horner P, Donders G, Cusini M, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol 2018; 32:1845.
          </a>
         </li>
         <li class="breakAll">
          Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Manual of Clinical Microbiology, 11th ed, Jorgensen J, Pfaller M, Carroll K, et al (Eds), ASM Press, Washington DC 2015. p.1088.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Canupp KC. Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures. J Clin Microbiol 2001; 39:4328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao L, Glass JI, Paralanov V, et al. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol 2010; 48:2715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Xiao L, Paralanov V, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn 2012; 14:437.
          </a>
         </li>
         <li class="breakAll">
          Clinical and Laboratory Standards Institute. M43-A: Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline. October 2011. https://clsi.org/media/1451/m43a_sample.pdf (Accessed on December 11, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 2010; 16:1649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pónyai K, Mihalik N, Ostorházi E, et al. Incidence and antibiotic susceptibility of genital mycoplasmas in sexually active individuals in Hungary. Eur J Clin Microbiol Infect Dis 2013; 32:1423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valentine-King MA, Brown MB. Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged Females. Antimicrob Agents Chemother 2017; 61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meygret A, Le Roy C, Renaudin H, et al. Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015. J Antimicrob Chemother 2018; 73:2696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bebear CM, Bové JM, Bebear C, Renaudin J. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones. Antimicrob Agents Chemother 1997; 41:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bébéar CM, de Barbeyrac B, Pereyre S, et al. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clin Microbiol Infect 2008; 14:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao L, Crabb DM, Duffy LB, et al. Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States. Antimicrob Agents Chemother 2012; 56:2780.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao L, Crabb DM, Duffy LB, et al. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int J Antimicrob Agents 2011; 37:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández J, Karau MJ, Cunningham SA, et al. Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States. Antimicrob Agents Chemother 2016; 60:4793.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Red Book: 2018 Report of the Committee on Infectious Diseases, 31st ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.867.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merchan LM, Hassan HE, Terrin ML, et al. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. Antimicrob Agents Chemother 2015; 59:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagiya H, Yoshida H, Yamamoto N, et al. Mycoplasma hominis periaortic abscess following heart-lung transplantation. Transpl Infect Dis 2017; 19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mian AN, Farney AC, Mendley SR. Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. Am J Transplant 2005; 5:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myers PO, Khabiri E, Greub G, Kalangos A. Mycoplasma hominis mediastinitis after acute aortic dissection repair. Interact Cardiovasc Thorac Surg 2010; 11:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eilers E, Moter A, Bollmann R, et al. Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney. J Clin Microbiol 2007; 45:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gerber L, Gaspert A, Braghetti A, et al. Ureaplasma and Mycoplasma in kidney allograft recipients-A case series and review of the literature. Transpl Infect Dis 2018; 20:e12937.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5508 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16223956" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Mycoplasmas and ureaplasmas as neonatal pathogens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19109084" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26482771" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : A cross-sectional study on the relationship of age, gestational age and HIV infection to bacterial vaginosis and genital mycoplasma infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8399923" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4697645" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Colonization with genital mycoplasmas in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5068553" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Sexual activity and vaginal colonization with genital mycoplasmas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6988709" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The genital mycoplasmas (first of two parts).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/105054" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Clinical and microbiological investigation of men with urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4912072" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Acquisition of mycoplasmata and T-strains during infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28263902" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8909826" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Infections due to species of Mycoplasma and Ureaplasma: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4988097" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasmas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11939406" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11120932" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16388480" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25463970" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Are Ureaplasma spp. a cause of nongonococcal urethritis? A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21917901" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Ureaplasma urealyticum is associated with nongonococcal urethritis among men with fewer lifetime sexual partners: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26378187" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20498103" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25525054" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Bacterial loads of Ureaplasma parvum contribute to the development of inflammatory responses in the male urethra.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3224973" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Infection of the epididymis by Ureaplasma urealyticum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/500801" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Diagnosis of Mycoplasma hominis pyelonephritis by demonstration of antibodies in urine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3047857" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Urinary infection stones caused by Ureaplasma urealyticum: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6665675" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Etiologic role of Mycoplasma hominis and Ureaplasma urealyticum in women with the acute urethral syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18166295" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Twenty percent of very preterm neonates (23-32 weeks of gestation) are born with bacteremia caused by genital Mycoplasmas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6665671" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23587772" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23960141" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Ureaplasma species: role in neonatal morbidities and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12552439" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25454994" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28078900" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Prevalence of Mycoplasma hominis and Ureaplasma urealyticum in women undergoing an initial infertility evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26311339" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24849820" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5415047" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Mycoplasma hominis and abortion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/47945" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Isolation of genital mycoplasmas from blood obtained shortly after vaginal delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18166302" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26518581" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16371861" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24445836" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8968928" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2891889" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12458575" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Mycoplasma hominis and Ureaplasma species brain abscess in a neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12506953" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Mycoplasma hominis scalp abscess in the newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5432161" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Abscess in newborn infants caused by Mycoplasma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8945717" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6882481" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Septic arthritis due to Mycoplasma hominis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7888535" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Mycoplasma hominis septic arthritis: two case reports and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26010188" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6689382" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The association of Mycoplasma hominis with arthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17033788" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Mycoplasma hominis osteitis in an immunocompetent man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27236775" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Bilateral periprosthetic joint infection with Ureaplasma urealyticum in an immunocompromised patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28711272" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The infection of Mycoplasma hominis after total knee replacement: Case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30642271" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Infection due to Mycoplasma hominis after left hip replacement: case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23188847" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Closed trauma, Mycoplasma hominis osteomyelitis, and the elusive diagnosis of Good's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1991913" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Ureaplasma urealyticum chronic osteomyelitis in a patient with hypogammaglobulinemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9821094" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28803865" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Ureaplasma urealyticum necrotizing soft tissue infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7053444" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Isolation of Mycoplasma hominis from the blood of men with multiple trauma and fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11168084" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Mycoplasma hominis catheter-related infection in a patient with multiple trauma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3293162" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Nongenitourinary infections caused by Mycoplasma hominis in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5109963" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Wound infection with Mycoplasma hominis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8941693" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Sternotomy infection with Mycoplasma hominis: a cause of "culture negative" wound infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28348780" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Pelvic abscess due to Mycoplasma hominis following caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12431497" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Mycoplasma hominis infection in heart and lung transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28438507" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29048510" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Donor-Derived Mycoplasma hominis and an Apparent Cluster of M. hominis Cases in Solid Organ Transplant Recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28575162" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Mycoplasma hominis Infections Transmitted Through Amniotic Tissue Product.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19369438" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Ureaplasma parvum as a cause of sternal wound infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11014630" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Prosthetic valve endocarditis caused by Mycoplasma hominis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14727231" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Mycoplasma endocarditis: two case reports and a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16940850" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Mycoplasma hominis endocarditis in a child with a complex congenital heart defect.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28814589" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Ureaplasma parvum causing life-threatening disease in a susceptible patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14301035" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : EXUDATIVE PHARYNGITIS FOLLOWING EXPERIMENTAL MYCOPLASMA HOMINIS: TYPE 1 INFECTION.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6665678" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17091241" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9367488" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Mycoplasma hominis pneumonia complicating bilateral lung transplantation: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9114209" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Extragenital Mycoplasma hominis infection in two liver transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21106079" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28109354" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28069785" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Postoperative Mycoplasma hominis brain abscess: keep it in mind!
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16722987" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Brain abscess caused by Mycoplasma hominis: a clinically recognizable entity?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18776733" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Successful treatment of multiple subdural empyemata caused by Mycoplasma hominis in a newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18790539" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Mycoplasma hominis meningitis in a neonate: case report and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18174297" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Ureaplasma urealyticum meningitis in an adult patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24478517" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Brain abscess caused by Ureaplasma urealyticum in an adult patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17148091" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Disseminated Ureaplasma urealyticum infection in a hypo-gammaglobulinaemic renal transplant patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25904745" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24315178" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Fatal hyperammonaemia caused by Mycoplasma hominis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29359847" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30863787" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Two Cases of Fatal Hyperammonemia Syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients Outside Lung Transplant Recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29924422" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29924422" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11724840" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20554828" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Detection and characterization of human Ureaplasma species and serovars by real-time PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22819362" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22819362" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20047607" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23686458" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Incidence and antibiotic susceptibility of genital mycoplasmas in sexually active individuals in Hungary.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28827422" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged Females.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29986031" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9021178" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18727805" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22371892" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21353494" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27246773" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27246773" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25385115" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28294481" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Mycoplasma hominis periaortic abscess following heart-lung transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15636628" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20826555" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Mycoplasma hominis mediastinitis after acute aortic dissection repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17229853" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29856498" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Ureaplasma and Mycoplasma in kidney allograft recipients-A case series and review of the literature.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
